Literature DB >> 11179733

Synthesis and biological activities of a new series of secosteroids: vitamin D phosphonate hybrids.

A Steinmeyer1, K Schwarz, M Haberey, G Langer, H Wiesinger.   

Abstract

By a structural combination of phosphonate and bisphosphonate moieties with the vitamin D skeleton a series of new vitamin D analogs was synthesized. Derivatives with 24beta-hydroxy- or 24-keto groups exerted considerable vitamin D activities in vitro while the hypercalcemic potentials were significantly reduced as compared to 1alpha,25-dihydroxyvitamin D(3) (calcitriol). Whereas the 24-hydroxy analogs did not influence bone formation in vivo in dosages below the hypercalcemic threshold, the 24-ketones were found to induce synthesis of new bone matrix in non-hypercalcemic doses. Vitamin D bisphosphonate hybrids, on the other hand, which did not elicit substantial vitamin D activities in vitro and tend to decrease serum calcium levels in vivo clearly induced osteoid formation in rats, indicating a mechanism of action different to calcitriol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179733     DOI: 10.1016/s0039-128x(00)00148-3

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  3 in total

1.  Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity.

Authors:  Débora G Salomón; Silvina M Grioli; Maximiliano Buschiazzo; Evangelina Mascaró; Cristian Vitale; Gabriel Radivoy; Manuel Perez; Yagamare Fall; Enrique A Mesri; Alejandro C Curino; María M Facchinetti
Journal:  ACS Med Chem Lett       Date:  2011-04-11       Impact factor: 4.345

2.  Preparation of novel (Z)-4-ylidenebenzo[b]furo[3,2-d][1,3]oxazines and their biological activity.

Authors:  Yukako Tabuchi; Yuko Ando; Hidemi Kanemura; Ikuo Kawasaki; Takahiro Ohishi; Masao Koida; Ryo Fukuyama; Hiromichi Nakamuta; Shunsaku Ohta; Kiyoharu Nishide; Yoshitaka Ohishi
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

Review 3.  Bisphosphonate-Based Conjugates and Derivatives as Potential Therapeutic Agents in Osteoporosis, Bone Cancer and Metastatic Bone Cancer.

Authors:  Zintle Mbese; Blessing A Aderibigbe
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.